SEMATIDE INJ. (Semaglutide) 0.25mg/0.5mg & 1mg FEROZSONS

Sematide® Injection (Semaglutide), also known as Ozempic®, is a GLP-1 receptor agonist indicated for the management of type 2 diabetes mellitus. It helps improve blood glucose control by stimulating insulin release, reducing glucagon secretion, and slowing gastric emptying, which supports better post-meal glucose regulation. This once-weekly injectable therapy may also assist with weight management as part of a comprehensive treatment plan that includes diet and exercise. Sematide® is recommended for use under the supervision of a qualified healthcare professional to ensure safe and effective treatment outcomes.